For research use only — not for human consumption

Senna Research
← Back to catalog
GLP1 SEMA research vial

Metabolic Research

In stock

GLP1 SEMA

5MG/vial

GLP-1 Sema is a semaglutide-based peptide studied in research models for its interaction with GLP-1 receptor signaling and metabolic regulation pathways [1,2] .

Professional pricing

Sign in or create a research account to see prices and add this material to your order. Access unlocks as soon as you create your account.

Sign in for pricing
  • In stock — ready to ship
  • Controlled handling
Shipment issuesWe do not accept returns on released material. Wrong item, damage, or a missing package is resolved directly.

Specifications

Product & molecular data

Lot & handling

SKU
SR-2260
Category
Metabolic Research
Storage
-20 °C, sealed, protected from light
Availability
In stock

Molecular

Sequence
Not available
Molecular formula
Not available
Molecular weight
Not available
CAS number
N/A
Storage conditions
−20 °C sealed and desiccated, protected from light
Format
Lyophilized Vial

Analytics

Testing & quality

When a lot certificate is on file we report identity, purity, and appearance. We publish analytical data only — never dosing information or outcome claims.

01

RP-HPLC

Chromatographic purity against a qualified reference standard.

02

LC-MS / ESI-MS

Identity by observed versus theoretical molecular mass.

03

Karl Fischer / Loss on Drying

Residual moisture in lyophilized material.

04

Endotoxin & Bioburden

Contaminant screening on raw material and finished lots.

Read the Quality Statement →

Research background

Published research context

Summary of the published literature this reference material is used in.

01

Telomere Biology

Investigated in cell-culture models of telomere maintenance and replicative ageing.

02

Gene Expression

Studied for reported effects on transcriptional regulation in experimental systems.

03

Senescence Models

Referenced in literature examining cellular senescence markers in vitro.

GLP-1 Receptor Interaction

GLP-1 receptor agonists are examined for their role in glucose-dependent signaling and endocrine pathway modulation [1]. Semaglutide-based constructs allow detailed analysis of receptor affinity and signaling duration.

Metabolic Pathway Research

Studies explore GLP-1 signaling in relation to insulin secretion pathways, appetite regulation markers, and energy balance mechanisms [2]. These investigations focus on pathway behavior rather than outcomes.

Structural Optimization

Semaglutide modifications enhance peptide stability and receptor engagement, supporting comparative signaling analysis across incretin analogs [1].

Key Specs

  • Peptide class: GLP-1 analog
  • Research context: incretin receptor signaling
  • References: PubChem, PubMed [1,2]

Referenced Citations

Related compounds

Mandatory research disclaimer

All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.

Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.

These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.